Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119217613 | 11921761 | 3 | F | 20151219 | 20160711 | 20160115 | 20160726 | EXP | PHHY2016TW001686 | NOVARTIS | 39.76 | YR | M | Y | 69.00000 | KG | 20160726 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119217613 | 11921761 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | U | 22068 | 300 | MG | CAPSULE | BID | |||||
| 119217613 | 11921761 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | U | 22068 | 300 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119217613 | 11921761 | 1 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119217613 | 11921761 | HO |
| 119217613 | 11921761 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119217613 | 11921761 | Cellulitis | |
| 119217613 | 11921761 | Constipation | |
| 119217613 | 11921761 | Erythema | |
| 119217613 | 11921761 | Eye pain | |
| 119217613 | 11921761 | Eye swelling | |
| 119217613 | 11921761 | Leukocytosis | |
| 119217613 | 11921761 | Pain in extremity | |
| 119217613 | 11921761 | Peripheral swelling | |
| 119217613 | 11921761 | Septal panniculitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119217613 | 11921761 | 1 | 20151217 | 0 | ||
| 119217613 | 11921761 | 2 | 20151218 | 0 |